Transport of Human Recombinant Brain-Derived Neurotrophic Factor (BDNF) Through the Rat Blood−Brain Barrier in Vivo Using Vector-Mediated Peptide Drug Delivery
- 1 January 1994
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 11 (5) , 738-746
- https://doi.org/10.1023/a:1018940732550
Abstract
The blood–brain barrier (BBB) transport of brain-derived neurotrophic factor (BDNF) in anesthetized rats was examined in the present studies using vector-mediated peptide drug delivery. Following...Keywords
This publication has 24 references indexed in Scilit:
- Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor.1994
- Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.Proceedings of the National Academy of Sciences, 1993
- Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.Proceedings of the National Academy of Sciences, 1992
- Transport of recombinant CD4 through the rat blood-brain barrier in vivo.1992
- Primary Structure and Biological Activity of Human Brain-Derived Neurotrophic FactorEndocrinology, 1991
- Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.Proceedings of the National Academy of Sciences, 1991
- Kinetics of lactate transport into rat liver in vivoMetabolism, 1990
- Neurotrophic Factors, Their Receptors, and the Signal Transduction Pathways They ActivatePublished by Cold Spring Harbor Laboratory ,1990
- Molecular cloning and expression of brain-derived neurotrophic factorNature, 1989
- Human Blood—Brain Barrier Insulin ReceptorJournal of Neurochemistry, 1985